Annual audited Standalone and Consolidated financial results of the Company for the quarter and financial year ended 31st March, 2026.
CHEMPLASTS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.5 pts less than Nifty Microcap 250 and 5.4 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Chemplast Sanmar reported annual results for FY26. Standalone revenue declined 9% to Rs 2,170 Cr from Rs 2,388 Cr in FY25, while consolidated revenue fell 2.8% to Rs 4,224 Cr from Rs 4,346 Cr. The company recorded a massive standalone loss of Rs 1,003 Cr after tax, significantly worse than the Rs 46 Cr loss in FY25, primarily due to an exceptional impairment charge of Rs 898 Cr on its investment in subsidiary Chemplast Cuddalore Vinyls Limited (CCVL). The impairment was triggered by unfavorable regulatory changes including non-imposition of anti-dumping duty on S-PVC, removal of customs duty on imports, and sharp price declines due to cheap imports and raw material volatility. No dividend was declared for FY25-26. Auditors BSR & Co. LLP issued an unmodified (clean) opinion on both standalone and consolidated results. The board also appointed Mr V S Radhakrishnan as Non-Executive Non-Independent Director and constituted a committee of Independent Directors to explore strategic reorganization and M&A opportunities.
The massive loss driven by the Rs 898 Cr impairment is concerning but non-cash in nature. The core Speciality Chemicals business remains operational, though revenue declined. The strategic review by the Independent Directors committee suggests the company may pursue restructuring or acquisitions to create shareholder value. The clean audit opinion provides some comfort despite the financial distress.